Kupffer cell-expressed membrane-bound TNF mediates melphalan hepatotoxicity via activation of both TNF receptors.
Isolated hepatic perfusion of nonresectable liver cancer using the combination of TNF and melphalan can be associated with a treatment-related hepatotoxicity. We investigated whether, apart from TNF, also melphalan is cytotoxic in primary murine liver cells in vitro and investigated mediators, mode of cell death, and cell types involved. Melphalan induced a caspase-dependent apoptosis in hepatocytes, which was not seen in liver cell preparations depleted of Kupffer cells. Neutralization of TNF prevented melphalan-induced apoptosis and liver cells derived from mice genetically deficient in either TNFR 1 or 2, but not from lpr mice lacking a functional CD95 receptor, were completely resistant. Cell-cell contact between hepatocytes and Kupffer cells was required for apoptosis to occur. Melphalan increased membrane-bound but not secreted TNF in Kupffer cells and inhibited recombinant TNF-alpha converting enzyme in vitro. Melphalan induced also severe hepatotoxicity in the isolated recirculating perfused mouse liver from wild-type mice but not from TNFR 1 or 2 knockout mice. In conclusion, this study shows that melphalan elicits membrane TNF on Kupffer cells due to inhibition of TNF processing and thereby initiates apoptosis of hepatocytes via obligatory activation of both TNFRs. The identification of this novel mechanism allows a causal understanding of melphalan-induced hepatotoxicity.
Kresse
Matthias
M
Biochemical Pharmacology, University of Konstanz, Konstanz, Germany.
Latta
Markus
M
Künstle
Gerald
G
Riehle
Hans-Martin
HM
van Rooijen
Nico
N
Hentze
Hannes
H
Tiegs
Gisa
G
Biburger
Markus
M
Lucas
Rudolf
R
Wendel
Albrecht
A
D051722:ADAM Proteins / Q000037:antagonists & inhibitors; D000072198:ADAM17 Protein; D000818:Animals; D017209:Apoptosis; D020169:Caspases / Q000378:metabolism; D002450:Cell Communication; D002478:Cells, Cultured; D056486:Chemical and Drug Induced Liver Injury; D022781:Hepatocytes / Q000473:pathology; D007728:Kupffer Cells / Q000378:metabolism*; D008107:Liver Diseases / Q000209:etiology; D008297:Male; D008558:Melphalan / Q000009:adverse effects*; D008565:Membrane Proteins; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000378:metabolism*; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D008565:Membrane Proteins; D047888:Receptors, Tumor Necrosis Factor, Type I; D047889:Receptors, Tumor Necrosis Factor, Type II; D014409:Tumor Necrosis Factor-alpha; D020169:Caspases; D051722:ADAM Proteins; D000072198:ADAM17 Protein; D008558:Melphalan